{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CXCL16", "DUSPs", "MAPK", "PI3K", "gastric carcinoma", "luteolin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28789432", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "06", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.3892/ol.2017.6380"], "Journal": {"ISSN": "1792-1074", "JournalIssue": {"Volume": "14", "Issue": "2", "PubDate": {"Year": "2017", "Month": "Aug"}}, "Title": "Oncology letters", "ISOAbbreviation": "Oncol Lett"}, "ArticleTitle": "Luteolin induces apoptosis <i>in vitro</i> through suppressing the MAPK and PI3K signaling pathways in gastric cancer.", "Pagination": {"StartPage": "1993", "EndPage": "2000", "MedlinePgn": "1993-2000"}, "Abstract": {"AbstractText": ["Luteolin, an active component of traditional Chinese medicine, exhibits potential for anti-tumor proliferation; however, the molecular events occurring in such process and the signal transduction pathways involved are currently unknown. Our group previously reported that luteolin inhibited proliferation and induced apoptosis in the gastric cancer cell line BGC-823. The aim of the present study was to investigate the mechanism by which the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) signaling pathways regulate the apoptosis <i>in vitro</i> of BGC-823 cells following treatment with luteolin. It was observed that luteolin induced apoptosis through the intrinsic pathway by increasing the levels of caspase-3, caspase-9 and cytochrome <i>c</i>, and the ratio of B-cell lymphoma (Bcl)-2 associated X protein (Bax) to Bcl-2. Luteolin suppressed the phosphorylation of extracellular signal-regulated kinase in the MAPK signaling pathway, as well as suppressing the phosphorylation of AKT, PI3K and mechanistic target of rapamycin in the PI3K signaling pathway. In addition, luteolin combined with LY294002 markedly increased the Bax/Bcl-2 ratio, while when combined with U0126, luteolin had less effects on the Bax/Bcl-2 ratio compared with luteolin treatment alone, suggesting that both the MAPK and PI3K signaling pathways are involved in the apoptosis induced by luteolin. Furthermore, luteolin attenuated the MAPK and PI3K signaling pathways by increasing the expression of specific dual-specificity phosphatases and decreasing the expression of chemokine (C-X-C motif) ligand 16 at the messenger RNA level, respectively. Taken together, the present results demonstrate that luteolin is a potential chemotherapeutic agent against gastric cancer by exerting a dual inhibition on the MAPK and PI3K signaling pathways."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, Xinjiang 830011, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Urumqi, Xinjiang 830011, P.R. China."}], "LastName": "Lu", "ForeName": "Xueying", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Key Laboratory of Special Species Conservation and Regulatory Biology, College of Life Science, Xinjiang Normal University, Urumqi, Xinjiang 830054, P.R. China."}], "LastName": "Li", "ForeName": "Yanhong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, Xinjiang 830011, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Urumqi, Xinjiang 830011, P.R. China."}], "LastName": "Li", "ForeName": "Xiaobo", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, Xinjiang 830011, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Urumqi, Xinjiang 830011, P.R. China."}], "LastName": "Aisa", "ForeName": "Haji Akber", "Initials": "HA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Lett", "NlmUniqueID": "101531236", "ISSNLinking": "1792-1074"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer; Lyon, France: 2013."}, {"Citation": "Rahman R, Asombang AW, Ibdah JA. Characteristics of gastric cancer in Asia. World J Gastroenterol. 2014;20:4483\u20134490. doi: 10.3748/wjg.v20.i16.4483.", "ArticleIdList": ["10.3748/wjg.v20.i16.4483", "PMC4000485", "24782601"]}, {"Citation": "Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol. 2009;135:29\u201338. doi: 10.1007/s00432-008-0425-z.", "ArticleIdList": ["10.1007/s00432-008-0425-z", "18523800"]}, {"Citation": "Green D, de Leon S Ponce, Leon-Rodriguez E, Sosa-Sanchez R. Adenocarcinoma of the stomach: Univariate and multivariate analysis of factors associated with survival. Am J Clin Oncol. 2002;25:84\u201389. doi: 10.1097/00000421-200202000-00018.", "ArticleIdList": ["10.1097/00000421-200202000-00018", "11823704"]}, {"Citation": "Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005;10(Suppl 3):S49\u2013S58. doi: 10.1634/theoncologist.10-90003-49.", "ArticleIdList": ["10.1634/theoncologist.10-90003-49", "16368871"]}, {"Citation": "Hejna M, W\u00f6hrer S, Schmidinger M, Raderer M. Postoperative chemotherapy for gastric cancer. Oncologist. 2006;11:136\u2013145. doi: 10.1634/theoncologist.11-2-136.", "ArticleIdList": ["10.1634/theoncologist.11-2-136", "16476834"]}, {"Citation": "Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, et al. Adjuvant chemotherapy in completely resected gastric cancer: A randomized phase III trial conducted by GOIRC. J Natl Cancer Inst. 2008;100:388\u2013398. doi: 10.1093/jnci/djn054.", "ArticleIdList": ["10.1093/jnci/djn054", "18334706"]}, {"Citation": "Yan Y, Wang LF, Wang RF. Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21:9717\u20139726. doi: 10.3748/wjg.v21.i33.9717.", "ArticleIdList": ["10.3748/wjg.v21.i33.9717", "PMC4562955", "26361418"]}, {"Citation": "Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem Sci. 2011;36:320\u2013328. doi: 10.1016/j.tibs.2011.03.006.", "ArticleIdList": ["10.1016/j.tibs.2011.03.006", "PMC3112285", "21531565"]}, {"Citation": "Trisciuoglio D, Iervolino A, Zupi G, Del Bufalo D. Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell. 2005;16:4153\u20134162. doi: 10.1091/mbc.E04-12-1087.", "ArticleIdList": ["10.1091/mbc.E04-12-1087", "PMC1196326", "15987743"]}, {"Citation": "Adeyinka A, Nui Y, Cherlet T, Snell L, Watson PH, Murphy LC. Activated mitogen- activated kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res. 2002;8:1747\u20131753.", "ArticleIdList": ["12060612"]}, {"Citation": "Kress TR, Raabe T, Feller SM. High Erk activity suppresses expression of the cell cycle inhibitor p27Kip1 in colorectal cancer cells. Cell Commun Signal. 2010;8:1. doi: 10.1186/1478-811X-8-1.", "ArticleIdList": ["10.1186/1478-811X-8-1", "PMC3780716", "20181064"]}, {"Citation": "Uzgare AR, Kaplan PJ, Greenberg NM. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate. 2003;55:128\u2013139. doi: 10.1002/pros.10212.", "ArticleIdList": ["10.1002/pros.10212", "12661038"]}, {"Citation": "Lin HL, Yang MH, Wu CW, Chen PM, Yang YP, Chu YR, Kao CL, Ku HH, Lo JF, Liou JP, et al. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway- mediated metastasis of gastric cancer. Int J Cancer. 2007;121:2547\u20132555. doi: 10.1002/ijc.22963.", "ArticleIdList": ["10.1002/ijc.22963", "17680560"]}, {"Citation": "An JY, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer. Int J Cancer. 2010;126:2904\u20132913.", "ArticleIdList": ["19739122"]}, {"Citation": "Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 2001;49:3106\u20133112. doi: 10.1021/jf000892m.", "ArticleIdList": ["10.1021/jf000892m", "11410016"]}, {"Citation": "Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, Mizuno M. Intestinal anti-inflammatory activity of luteolin: Role of the aglycone in NF-\u03baB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors. 2013;39:522\u2013533. doi: 10.1002/biof.1091.", "ArticleIdList": ["10.1002/biof.1091", "23460110"]}, {"Citation": "Ashokkumar P, Sudhandiran P. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother. 2008;62:590\u2013597. doi: 10.1016/j.biopha.2008.06.031.", "ArticleIdList": ["10.1016/j.biopha.2008.06.031", "18692983"]}, {"Citation": "Ashokkumar P, Sudhandiran G. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/\u03b2-catenin pathway. Invest New Drugs. 2011;29:273\u2013284. doi: 10.1007/s10637-009-9359-9.", "ArticleIdList": ["10.1007/s10637-009-9359-9", "20013030"]}, {"Citation": "Sakurai MA, Ozaki Y, Okuzaki D, Naito Y, Sasakura T, Okamoto A, Tabara H, Inoue T, Hagiyama M, Ito A, et al. Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. PLoS One. 2014;9:e100124. doi: 10.1371/journal.pone.0100124.", "ArticleIdList": ["10.1371/journal.pone.0100124", "PMC4074034", "24971999"]}, {"Citation": "Wu B, Zhang Q, Shen WM, Zhu J. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem. 2008;313:125\u2013132. doi: 10.1007/s11010-008-9749-x.", "ArticleIdList": ["10.1007/s11010-008-9749-x", "18398671"]}, {"Citation": "Wang HY, Quan K, Jiang YL, Wu JG, Tang XW. Effect of Luteolin and its combination with chemotherapeutic drugs on cytotoxicity of cancer cells. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010;39:30\u201336. (In Chinese)", "ArticleIdList": ["20175233"]}, {"Citation": "Ding S, Hu A, Hu Y, Ma J, Weng P, Dai J. Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest. Tumour Biol. 2014;35:3053\u20133060. doi: 10.1007/s13277-013-1396-5.", "ArticleIdList": ["10.1007/s13277-013-1396-5", "24287949"]}, {"Citation": "Shi RX, Ong CN, Shen HM. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells. Oncogene. 2004;23:7712\u20137721. doi: 10.1038/sj.onc.1208046.", "ArticleIdList": ["10.1038/sj.onc.1208046", "15334063"]}, {"Citation": "Manju V, Nalini N. Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Funct. 2007;25:189\u2013194. doi: 10.1002/cbf.1305.", "ArticleIdList": ["10.1002/cbf.1305", "16850523"]}, {"Citation": "Samy RP, Gopalakrishnakone P, Ignacimuthu S. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Chem Biol Interact. 2006;164:1\u201314. doi: 10.1016/j.cbi.2006.08.018.", "ArticleIdList": ["10.1016/j.cbi.2006.08.018", "17064676"]}, {"Citation": "Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009;27:2712\u20132725. doi: 10.1200/JCO.2008.20.6235.", "ArticleIdList": ["10.1200/JCO.2008.20.6235", "PMC2690394", "19414669"]}, {"Citation": "Pandurangan AK, Dharmalingam P, Sadagopan SK Ananda, Ganapasam S. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev. 2012;13:1569\u20131573. doi: 10.7314/APJCP.2012.13.4.1569.", "ArticleIdList": ["10.7314/APJCP.2012.13.4.1569", "22799368"]}, {"Citation": "Sagawa H, Naiki-Ito A, Kato H, Naiki T, Yamashita Y, Suzuki S, Sato S, Shiomi K, Kato A, Kuno T, et al. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats. Carcinogenesis. 2015;36:1539\u20131549.", "ArticleIdList": ["26494227"]}, {"Citation": "Kasala ER, Bodduluru LN, Barua CC, Gogoi R. Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis. Biomed Pharmacother. 2016;82:568\u2013577. doi: 10.1016/j.biopha.2016.05.042.", "ArticleIdList": ["10.1016/j.biopha.2016.05.042", "27470398"]}, {"Citation": "Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20131108. doi: 10.1038/nprot.2008.73.", "ArticleIdList": ["10.1038/nprot.2008.73", "18546601"]}, {"Citation": "Lu Xueying, Li Yanhong, Xiao Xiangwen, Akber Aisa Haji, Li Xiaobo. Study on inhibition of luteolin on proliferation of human gastric cancer cell line BGC-823. Mod J Integr Tradit Chinese Western Med. 2012;3:246\u2013249."}, {"Citation": "Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770\u2013776. doi: 10.1038/35037710.", "ArticleIdList": ["10.1038/35037710", "11048727"]}, {"Citation": "Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science. 1998;281:1312\u20131316. doi: 10.1126/science.281.5381.1312.", "ArticleIdList": ["10.1126/science.281.5381.1312", "9721091"]}, {"Citation": "Pradelli LA, B\u00e9n\u00e9teau M, Ricci JE. Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci. 2010;67:1589\u20131597. doi: 10.1007/s00018-010-0285-y.", "ArticleIdList": ["10.1007/s00018-010-0285-y", "20151314"]}, {"Citation": "Otera H, Mihara K. Mitochondrial dynamics: Functional link with apoptosis. Int J Cell Biol. 2012;2012:821676. doi: 10.1155/2012/821676.", "ArticleIdList": ["10.1155/2012/821676", "PMC3320010", "22536251"]}, {"Citation": "Kumar A, Ganini D, Mason RP. Role of cytochrome c in \u03b1-synuclein radical formation: Implications of \u03b1-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson's disease. Mol Neurodegener. 2016;11:70. doi: 10.1186/s13024-016-0135-y.", "ArticleIdList": ["10.1186/s13024-016-0135-y", "PMC5122029", "27884192"]}, {"Citation": "Lopez-Cruzan M, Sharma R, Tiwari M, Karbach S, Holstein D, Martin CR, Lechleiter JD, Herman B. Caspase-2 resides in the mitochondria and mediates apoptosis directly from the mitochondrial compartment. Cell Death Discov. 2016;2(pii):16005. doi: 10.1038/cddiscovery.2016.5.", "ArticleIdList": ["10.1038/cddiscovery.2016.5", "PMC4806400", "27019748"]}, {"Citation": "Rong Y, Distelhorst CW. Bcl-2 protein family members: Versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol. 2008;70:73\u201391. doi: 10.1146/annurev.physiol.70.021507.105852.", "ArticleIdList": ["10.1146/annurev.physiol.70.021507.105852", "17680735"]}, {"Citation": "Li C, Wu X, Sun R, Zhao P, Liu F, Zhang C. Croton tiglium extract induces apoptosis via Bax/Bcl-2 pathways in human lung cancer A549 cells. Asian Pac J Cancer Prev. 2016;17:4893\u20134898.", "ArticleIdList": ["PMC5454692", "28032492"]}, {"Citation": "Zhang S, Qin F, Yang L, Xian J, Zou Q, Jin H, Wang L, Zhang L. Nucleophosmin mutations induce chemosensitivity in THP-1 leukemia cells by suppressing NF-\u03baB Activity and regulating Bax/Bcl-2 expression. J Cancer. 2016;7:2270\u20132279. doi: 10.7150/jca.16010.", "ArticleIdList": ["10.7150/jca.16010", "PMC5166537", "27994664"]}, {"Citation": "Csibi A, Fendt SM, Li C, Poulogiannis G, Choo AY, Chapski DJ, Jeong SM, Dempsey JM, Parkhitko A, Morrison T, et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell. 2013;153:840\u2013854. doi: 10.1016/j.cell.2013.04.023.", "ArticleIdList": ["10.1016/j.cell.2013.04.023", "PMC3684628", "23663782"]}, {"Citation": "Sapey E, Greenwood H, Walton G, Mann E, Love A, Aaronson N, Insall RH, Stockley RA, Lord JM. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: Toward targeted treatments for immunosenescence. Blood. 2014;123:239\u2013248. doi: 10.1182/blood-2013-08-519520.", "ArticleIdList": ["10.1182/blood-2013-08-519520", "PMC3888290", "24191150"]}, {"Citation": "Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: Critical regulators with diverse cellular targets. Biochem J. 2009;418:475\u2013489. doi: 10.1042/BJ20082234.", "ArticleIdList": ["10.1042/BJ20082234", "19228121"]}, {"Citation": "Theodosiou A, Ashworth A. MAP kinase phosphatases. Genome Biol. 2002;3 doi: 10.1186/gb-2002-3-7-reviews3009. REVIEWS3009.", "ArticleIdList": ["10.1186/gb-2002-3-7-reviews3009", "PMC139386", "12184814"]}, {"Citation": "Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: A gene family for control of MAP kinase function. FASEB J. 2000;14:6\u201316.", "ArticleIdList": ["10627275"]}, {"Citation": "Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol. 2000;12:186\u2013192. doi: 10.1016/S0955-0674(99)00075-7.", "ArticleIdList": ["10.1016/S0955-0674(99)00075-7", "10712927"]}, {"Citation": "Chalabi-Dchar M, Cassant-Sourdy S, Duluc C, Fanjul M, Lulka H, Samain R, Roche C, Breibach F, Delisle MB, Poupot M, et al. Loss of somatostatin receptor subtype 2 promotes growth of KRAS-induced pancreatic tumors in mice by activating PI3K signaling and overexpression of CXCL16. Gastroenterology. 2015;148:1452\u20131465. doi: 10.1053/j.gastro.2015.02.009.", "ArticleIdList": ["10.1053/j.gastro.2015.02.009", "25683115"]}, {"Citation": "Chiu FL, Lin JK. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate. 2008;68:61\u201371. doi: 10.1002/pros.20690.", "ArticleIdList": ["10.1002/pros.20690", "18008333"]}, {"Citation": "Lim DY, Jeong Y, Tyner AL, Park JH. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastrointest Liver Physiol. 2007;292:G66\u2013G75. doi: 10.1152/ajpgi.00248.2006.", "ArticleIdList": ["10.1152/ajpgi.00248.2006", "16901994"]}, {"Citation": "Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802:396\u2013405. doi: 10.1016/j.bbadis.2009.12.009.", "ArticleIdList": ["10.1016/j.bbadis.2009.12.009", "20079433"]}, {"Citation": "Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838\u20132849. doi: 10.1038/sj.onc.1207556.", "ArticleIdList": ["10.1038/sj.onc.1207556", "15077147"]}, {"Citation": "Chang L, Karin M. Mammalian MAP kinas signaling cascades. Nature. 2001;410:37\u201340. doi: 10.1038/35068583.", "ArticleIdList": ["10.1038/35068583", "11242034"]}, {"Citation": "McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, et al. Roles of the Raf/MEK/ERK Pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773:1263\u20131284. doi: 10.1016/j.bbamcr.2006.10.001.", "ArticleIdList": ["10.1016/j.bbamcr.2006.10.001", "PMC2696318", "17126425"]}, {"Citation": "Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435:677\u2013681. doi: 10.1038/nature03579.", "ArticleIdList": ["10.1038/nature03579", "15902208"]}, {"Citation": "Huang CY, Tan TH. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012;2:24. doi: 10.1186/2045-3701-2-24.", "ArticleIdList": ["10.1186/2045-3701-2-24", "PMC3406950", "22769588"]}, {"Citation": "Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: Manipulating MAP kinase signaling and immune responses. Nat Rev Drug Discov. 2007;6:391\u2013403. doi: 10.1038/nrd2289.", "ArticleIdList": ["10.1038/nrd2289", "17473844"]}, {"Citation": "Nunes-Xavier C, Rom\u00e1-Mateo C, R\u00edos P, T\u00e1rrega C, Cejudo-Mar\u00edn R, Tabernero L, Pulido R. Dual-specificity MAP kinase phosphatases as targets of cancer treatment. Anticancer Agents Med Chem. 2011;11:109\u2013132. doi: 10.2174/187152011794941190.", "ArticleIdList": ["10.2174/187152011794941190", "21288197"]}, {"Citation": "Duronio V. The life of a cell: Apoptosis regulation by the PI3K/PKB pathway. Biochem J. 2008;415:333\u2013344. doi: 10.1042/BJ20081056.", "ArticleIdList": ["10.1042/BJ20081056", "18842113"]}, {"Citation": "Guo C, Yang M, Jing L, Wang J, Yu Y, Li Y, Duan J, Zhou X, Li Y, Sun Z. Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK/Bcl-2 and PI3K/Akt/mTOR signaling. Int J Nanomedicine. 2016;11:5257\u20135276. doi: 10.2147/IJN.S112030.", "ArticleIdList": ["10.2147/IJN.S112030", "PMC5066858", "27785026"]}, {"Citation": "Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL, Henson PM. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 2004;279:21085\u201321095. doi: 10.1074/jbc.M400063200.", "ArticleIdList": ["10.1074/jbc.M400063200", "14766748"]}, {"Citation": "Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267:2003\u20132006. doi: 10.1126/science.7701324.", "ArticleIdList": ["10.1126/science.7701324", "7701324"]}, {"Citation": "Scheid MP, Lauener RW, Duronio V. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: Phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem J. 1995;312:159\u2013162. doi: 10.1042/bj3120159.", "ArticleIdList": ["10.1042/bj3120159", "PMC1136239", "7492306"]}, {"Citation": "Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. Breast Cancer Res Treat. 2014;147:381\u2013387. doi: 10.1007/s10549-014-3081-9.", "ArticleIdList": ["10.1007/s10549-014-3081-9", "PMC4174407", "25108739"]}, {"Citation": "Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436\u2013445. doi: 10.1056/NEJM199802123380706.", "ArticleIdList": ["10.1056/NEJM199802123380706", "9459648"]}, {"Citation": "Struyf S, Proost P, Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol. 2003;81:1\u201344. doi: 10.1016/S0065-2776(03)81001-5.", "ArticleIdList": ["10.1016/S0065-2776(03)81001-5", "14711052"]}, {"Citation": "Guerreiro R, Santos-Costa Q, Azevedo-Pereira JM. The chemokines and their receptors: Characteristics and physiological functions. Acta Med Port. 2011;24(Suppl 4):S967\u2013S976. (In Portuguese)", "ArticleIdList": ["22863506"]}, {"Citation": "Xing YN, Xu XY, Nie XC, Yang X, Yu M, Xu HM, Liu YP, Takano Y, Zheng HC. Role and clinicopath- ologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas. Hum Pathol. 2012;43:2299\u20132307. doi: 10.1016/j.humpath.2011.08.027.", "ArticleIdList": ["10.1016/j.humpath.2011.08.027", "22863086"]}, {"Citation": "Wang J, Lu Y, Wang J, Koch AE, Zhang J, Taichman RS. CXCR6 induces prostate cancer progression by the AKT/Mammalian target of rapamycin signaling pathway. Cancer Res. 2008;68:10367\u201310376. doi: 10.1158/0008-5472.CAN-08-2780.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-2780", "PMC2884407", "19074906"]}, {"Citation": "Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem. 2004;279:3188\u20133196. doi: 10.1074/jbc.M311660200.", "ArticleIdList": ["10.1074/jbc.M311660200", "14625285"]}, {"Citation": "Deng L, Chen N, Li Y, Zheng H, Lei Q. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochim Biophys Acta. 2010;1806:42\u201349.", "ArticleIdList": ["20122997"]}, {"Citation": "Singh R, Kapur N, Mir H, Singh N, Lillard JW, Jr, Singh S. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and \u03b1v\u03b23 integrin clustering. Oncotarget. 2016;7:7343\u20137353.", "ArticleIdList": ["PMC4872790", "26799186"]}, {"Citation": "Hu ZB, Chen Y, Gong YX, Gao M, Zhang Y, Wang GH, Tang RN, Liu H, Liu BC, Ma KL. Activation of the CXCL16/CXCR6 pathway by inflammation contributes to atherosclerosis in patients with End-stage renal disease. Int J Med Sci. 2016;13:858\u2013867. doi: 10.7150/ijms.16724.", "ArticleIdList": ["10.7150/ijms.16724", "PMC5118757", "27877078"]}, {"Citation": "Hald SM, Kiselev Y, Al-Saad S, Richardsen E, Johannessen C, Eilertsen M, Kilvaer TK, Al-Shibli K, Andersen S, Busund LT, et al. Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. 2016;16:916. doi: 10.1186/s12885-016-2954-1.", "ArticleIdList": ["10.1186/s12885-016-2954-1", "PMC5122019", "27884136"]}]}], "History": [{"Year": "2015", "Month": "9", "Day": "30"}, {"Year": "2017", "Month": "3", "Day": "10"}, {"Year": "2017", "Month": "8", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "6", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28789432", "PMC5530081", "10.3892/ol.2017.6380", "OL-0-0-6380"]}}]}